William Blair Investment Management LLC Sells 31,716 Shares of Maximus, Inc. $MMS

William Blair Investment Management LLC lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 313,594 shares of the health services provider’s stock after selling 31,716 shares during the period. William Blair Investment Management LLC’s holdings in Maximus were worth $27,069,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Jefferies Financial Group Inc. increased its stake in shares of Maximus by 453.8% during the fourth quarter. Jefferies Financial Group Inc. now owns 60,361 shares of the health services provider’s stock worth $5,210,000 after purchasing an additional 49,461 shares during the period. LSV Asset Management grew its position in Maximus by 35.5% during the fourth quarter. LSV Asset Management now owns 163,600 shares of the health services provider’s stock worth $14,122,000 after buying an additional 42,900 shares in the last quarter. Kingdom Financial Group LLC. acquired a new stake in Maximus during the fourth quarter worth approximately $141,000. PNC Financial Services Group Inc. grew its position in Maximus by 84.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,751 shares of the health services provider’s stock worth $583,000 after buying an additional 3,085 shares in the last quarter. Finally, ProShare Advisors LLC grew its position in Maximus by 4.4% during the fourth quarter. ProShare Advisors LLC now owns 12,617 shares of the health services provider’s stock worth $1,089,000 after buying an additional 537 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on MMS shares. Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Maximus Trading Down 0.1%

Shares of MMS stock opened at $61.09 on Tuesday. The stock’s fifty day moving average price is $65.26 and its two-hundred day moving average price is $77.89. The company has a market cap of $3.21 billion, a PE ratio of 9.15 and a beta of 0.60. Maximus, Inc. has a fifty-two week low of $56.92 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company’s revenue was down 4.1% compared to the same quarter last year. During the same quarter last year, the business posted $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities analysts predict that Maximus, Inc. will post 8.4 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, May 15th. Maximus’s dividend payout ratio (DPR) is currently 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.